DCFDA |
|||
| GW3799-1 | Glentham Life Sciences | 1 | EUR 135.6 |
DCFDA |
|||
| GW3799-5 | Glentham Life Sciences | 5 | EUR 423.4 |
Carboxy-DCFDA |
|||
| GW5389 | Glentham Life Sciences | 100mg | EUR 1041.08 |
Carboxy-DCFDA |
|||
| GW5389-1 | Glentham Life Sciences | 1 | EUR 999.9 |
Carboxy-DCFDA |
|||
| GW5389-100 | Glentham Life Sciences | 100 | EUR 207.1 |
Carboxy-DCFDA N-succinimidyl ester |
|||
| GW9790 | Glentham Life Sciences | 50mg | EUR 1495.83 |
Carboxy-DCFDA N-succinimidyl ester |
|||
| GW9790-250 | Glentham Life Sciences | 250 | EUR 1427.9 |
Carboxy-DCFDA N-succinimidyl ester |
|||
| GW9790-50 | Glentham Life Sciences | 50 | EUR 379.2 |
Human complement factor D-CFD-ELISA Kit |
|||
| QY-E04079 | Qayee Biotechnology | 96T | EUR 450 |
CD7(124.1D1), CF568 conjugate, 0.1mg/mL |
|||
| BNC681046-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF568 conjugate, 0.1mg/mL |
|||
| BNC681046-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF594 conjugate, 0.1mg/mL |
|||
| BNC941046-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF594 conjugate, 0.1mg/mL |
|||
| BNC941046-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF647 conjugate, 0.1mg/mL |
|||
| BNC471046-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF647 conjugate, 0.1mg/mL |
|||
| BNC471046-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF488A conjugate, 0.1mg/mL |
|||
| BNC881046-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF488A conjugate, 0.1mg/mL |
|||
| BNC881046-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF640R conjugate, 0.1mg/mL |
|||
| BNC401046-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF640R conjugate, 0.1mg/mL |
|||
| BNC401046-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF405S conjugate, 0.1mg/mL |
|||
| BNC041046-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD7(124.1D1), CF405S conjugate, 0.1mg/mL |
|||
| BNC041046-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Rabbit Anti Human IGHG4 Monoclonal Clone DCF-9 |
|||
| IRBAHUIGHG4DCF9C100UL | Innovative research | each | EUR 496 |
|
Description: Rabbit Anti Human IGHG4 Monoclonal Clone DCF-9 |
|||
DCFBC |
|||
| MBS5775025-5mg | MyBiosource | 5(mg | EUR 915 |
DCFBC |
|||
| MBS5775025-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
DCFBC |
|||
| T25293-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: DCFBC |
|||
DCFBC |
|||
| T25293-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: DCFBC |
|||
DCFBC |
|||
| T25293-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: DCFBC |
|||
DCFBC |
|||
| T25293-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: DCFBC |
|||
DCFBC |
|||
| T25293-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: DCFBC |
|||
DCFBC F-18 |
|||
| MBS5775026-5mg | MyBiosource | 5(mg | EUR 915 |
DCFBC F-18 |
|||
| MBS5775026-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
DCFPYL |
|||
| MBS5780845-5mg | MyBiosource | 5(mg | EUR 915 |
DCFPYL |
|||
| MBS5780845-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
DCFPYL |
|||
| T31224-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: DCFPYL |
|||
DCFPYL |
|||
| T31224-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: DCFPYL |
|||
DCFPYL |
|||
| T31224-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: DCFPYL |
|||
DCFPYL |
|||
| T31224-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: DCFPYL |
|||
DCFPYL |
|||
| T31224-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: DCFPYL |
|||
DCFBC F-18 |
|||
| T25294-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: DCFBC F-18 |
|||
DCFBC F-18 |
|||
| T25294-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: DCFBC F-18 |
|||
DCFBC F-18 |
|||
| T25294-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: DCFBC F-18 |
|||
DCFBC F-18 |
|||
| T25294-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: DCFBC F-18 |
|||
DCFBC F-18 |
|||
| T25294-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: DCFBC F-18 |
|||
Dcfpyl F-18 |
|||
| MBS5775027-5mg | MyBiosource | 5(mg | EUR 915 |
Dcfpyl F-18 |
|||
| MBS5775027-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Dcfpyl F-18 |
|||
| T25295-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Dcfpyl F-18 |
|||
Dcfpyl F-18 |
|||
| T25295-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Dcfpyl F-18 |
|||
Dcfpyl F-18 |
|||
| T25295-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Dcfpyl F-18 |
|||
Dcfpyl F-18 |
|||
| T25295-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Dcfpyl F-18 |
|||
Dcfpyl F-18 |
|||
| T25295-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Dcfpyl F-18 |
|||
Bax(2D2), CF568 conjugate, 0.1mg/mL |
|||
| BNC680004-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF568 conjugate, 0.1mg/mL |
|||
| BNC680004-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF594 conjugate, 0.1mg/mL |
|||
| BNC940004-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF594 conjugate, 0.1mg/mL |
|||
| BNC940004-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF647 conjugate, 0.1mg/mL |
|||
| BNC470004-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF647 conjugate, 0.1mg/mL |
|||
| BNC470004-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF488A conjugate, 0.1mg/mL |
|||
| BNC880004-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF488A conjugate, 0.1mg/mL |
|||
| BNC880004-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF640R conjugate, 0.1mg/mL |
|||
| BNC400004-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF640R conjugate, 0.1mg/mL |
|||
| BNC400004-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF405S conjugate, 0.1mg/mL |
|||
| BNC040004-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Bax(2D2), CF405S conjugate, 0.1mg/mL |
|||
| BNC040004-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD147(8D6), CF568 conjugate, 0.1mg/mL |
|||
| BNC680424-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD147(8D6), CF568 conjugate, 0.1mg/mL |
|||
| BNC680424-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD84(152-1D5), CF568 conjugate, 0.1mg/mL |
|||
| BNC680985-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD84(152-1D5), CF568 conjugate, 0.1mg/mL |
|||
| BNC680985-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD84(153-4D9), CF568 conjugate, 0.1mg/mL |
|||
| BNC681049-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD84(153-4D9), CF568 conjugate, 0.1mg/mL |
|||
| BNC681049-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD147(8D6), CF594 conjugate, 0.1mg/mL |
|||
| BNC940424-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD147(8D6), CF594 conjugate, 0.1mg/mL |
|||
| BNC940424-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD84(152-1D5), CF594 conjugate, 0.1mg/mL |
|||
| BNC940985-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||